Carmona, Wilfredo E.

HRN: 27-56-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
CEFTAZIDIME 1GM (VIAL)
07/29/2025
08/04/2025
IV
1g
Q8h
Capmr
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: